At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, manufacturing, and controls) and Bioavailability Enhancement at Lonza, gave ...

An international team involving the Institute of Chemical Research, a joint center of the University of Seville and the ...

AI drives decision inputs: In 2025, both big pharma and small pharma use advanced predictive modeling, digital twins, and AI-powered analytics throughout R&D and regulatory processes. This reduces ...

Researchers at the University created an AI model called EZSpecificity to test how certain enzymes and substrates bind to ...

Lupin commissions oncology block at Vizag plant, expanding CDMO capabilities for high-potent APIs and oncology drug ...

AI, ML, and statistical algorithms guide solubilization method selection, demonstrated with compound CVN424. In a poster presentation at AAPS PharmSci 360, by Dineli Ranathunga, PhD, indicates that AI ...

The US Food and Drug Administration (FDA) has a new chief drug regulator, with industry veteran Dr Richard Pazdur taking the helm amid a period of senior leadership instability at the agency. Pazdur, ...

This completion is a crucial requirement in the approval process for a drug.

Innovation in drug development has never moved faster! New modalities, real-world evidence, complex patient stratification, and AI are reshaping what’s possible. Yet one of the biggest bottlenecks ...

Both The U.S. Department of Health and Human Services (HHS) and the FDA announced the appointment of Richard Pazdur, M.D., as director of the Center for Drug Evaluation and Research (CDER). 1 ...

Finance Income, net, was $0.1 million for the three months ended September 30, 2025, compared to $1.5 million in the same ...

A UK team claims to have cracked one of life's oldest mysteries - how to stop the body breaking down with age - and is now preparing human trials of a ‘Fountain of Youth' pill.